Literature DB >> 34230558

Untangling the genetic link between type 1 and type 2 diabetes using functional genomics.

Denis M Nyaga1, Mark H Vickers1, Craig Jefferies1,2, Tayaza Fadason1, Justin M O'Sullivan3,4.   

Abstract

There is evidence pointing towards shared etiological features between type 1 diabetes (T1D) and type 2 diabetes (T2D) despite both phenotypes being considered genetically distinct. However, the existence of shared genetic features for T1D and T2D remains complex and poorly defined. To better understand the link between T1D and T2D, we employed an integrated functional genomics approach involving extensive chromatin interaction data (Hi-C) and expression quantitative trait loci (eQTL) data to characterize the tissue-specific impacts of single nucleotide polymorphisms associated with T1D and T2D. We identified 195 pleiotropic genes that are modulated by tissue-specific spatial eQTLs associated with both T1D and T2D. The pleiotropic genes are enriched in inflammatory and metabolic pathways that include mitogen-activated protein kinase activity, pertussis toxin signaling, and the Parkinson's disease pathway. We identified 8 regulatory elements within the TCF7L2 locus that modulate transcript levels of genes involved in immune regulation as well as genes important in the etiology of T2D. Despite the observed gene and pathway overlaps, there was no significant genetic correlation between variant effects on T1D and T2D risk using European ancestral summary data. Collectively, our findings support the hypothesis that T1D and T2D specific genetic variants act through genetic regulatory mechanisms to alter the regulation of common genes, and genes that co-locate in biological pathways, to mediate pleiotropic effects on disease development. Crucially, a high risk genetic profile for T1D alters biological pathways that increase the risk of developing both T1D and T2D. The same is not true for genetic profiles that increase the risk of developing T2D. The conversion of information on genetic susceptibility to the protein pathways that are altered provides an important resource for repurposing or designing novel therapies for the management of diabetes.

Entities:  

Year:  2021        PMID: 34230558     DOI: 10.1038/s41598-021-93346-x

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  85 in total

Review 1.  beta-Cell death during progression to diabetes.

Authors:  D Mathis; L Vence; C Benoist
Journal:  Nature       Date:  2001-12-13       Impact factor: 49.962

2.  Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.

Authors:  T Tuomi; A Carlsson; H Li; B Isomaa; A Miettinen; A Nilsson; M Nissén; B O Ehrnström; B Forsén; B Snickars; K Lahti; C Forsblom; C Saloranta; M R Taskinen; L C Groop
Journal:  Diabetes       Date:  1999-01       Impact factor: 9.461

Review 3.  The accelerator hypothesis: weight gain as the missing link between Type I and Type II diabetes.

Authors:  T J Wilkin
Journal:  Diabetologia       Date:  2001-07       Impact factor: 10.122

Review 4.  Inflammatory mediators and islet beta-cell failure: a link between type 1 and type 2 diabetes.

Authors:  Marc Y Donath; Joachim Størling; Kathrin Maedler; Thomas Mandrup-Poulsen
Journal:  J Mol Med (Berl)       Date:  2003-07-18       Impact factor: 4.599

5.  Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease.

Authors:  T Tuomi; L C Groop; P Z Zimmet; M J Rowley; W Knowles; I R Mackay
Journal:  Diabetes       Date:  1993-02       Impact factor: 9.461

6.  Analysis of the type 2 diabetes-associated single nucleotide polymorphisms in the genes IRS1, KCNJ11, and PPARG2 in type 1 diabetes.

Authors:  Christina Eftychi; Joanna M M Howson; Bryan J Barratt; Adrian Vella; Felicity Payne; Deborah J Smyth; Rebecca C J Twells; Neil M Walker; Helen E Rance; Eva Tuomilehto-Wolf; Jaakko Tuomilehto; Dag E Undlien; Kjersti S Rønningen; Cristian Guja; Constantin Ionescu-Tîirgovişte; David A Savage; John A Todd
Journal:  Diabetes       Date:  2004-03       Impact factor: 9.461

7.  Identification of non-HLA genes associated with development of islet autoimmunity and type 1 diabetes in the prospective TEDDY cohort.

Authors:  Ashok Sharma; Xiang Liu; David Hadley; William Hagopian; Wei-Min Chen; Suna Onengut-Gumuscu; Carina Törn; Andrea K Steck; Brigitte I Frohnert; Marian Rewers; Anette-G Ziegler; Åke Lernmark; Jorma Toppari; Jeffrey P Krischer; Beena Akolkar; Stephen S Rich; Jin-Xiong She
Journal:  J Autoimmun       Date:  2018-01-05       Impact factor: 14.511

Review 8.  The SEARCH for Diabetes in Youth study: rationale, findings, and future directions.

Authors:  Richard F Hamman; Ronny A Bell; Dana Dabelea; Ralph B D'Agostino; Lawrence Dolan; Giuseppina Imperatore; Jean M Lawrence; Barbara Linder; Santica M Marcovina; Elizabeth J Mayer-Davis; Catherine Pihoker; Beatriz L Rodriguez; Sharon Saydah
Journal:  Diabetes Care       Date:  2014-12       Impact factor: 19.112

9.  Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes.

Authors:  Angli Xue; Yang Wu; Zhihong Zhu; Futao Zhang; Kathryn E Kemper; Zhili Zheng; Loic Yengo; Luke R Lloyd-Jones; Julia Sidorenko; Yeda Wu; Allan F McRae; Peter M Visscher; Jian Zeng; Jian Yang
Journal:  Nat Commun       Date:  2018-07-27       Impact factor: 14.919

10.  Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ancestry meta-analysis.

Authors:  Marijana Vujkovic; Jacob M Keaton; Kyong-Mi Chang; Benjamin F Voight; Danish Saleheen; Julie A Lynch; Donald R Miller; Jin Zhou; Catherine Tcheandjieu; Jennifer E Huffman; Themistocles L Assimes; Kimberly Lorenz; Xiang Zhu; Austin T Hilliard; Renae L Judy; Jie Huang; Kyung M Lee; Derek Klarin; Saiju Pyarajan; John Danesh; Olle Melander; Asif Rasheed; Nadeem H Mallick; Shahid Hameed; Irshad H Qureshi; Muhammad Naeem Afzal; Uzma Malik; Anjum Jalal; Shahid Abbas; Xin Sheng; Long Gao; Klaus H Kaestner; Katalin Susztak; Yan V Sun; Scott L DuVall; Kelly Cho; Jennifer S Lee; J Michael Gaziano; Lawrence S Phillips; James B Meigs; Peter D Reaven; Peter W Wilson; Todd L Edwards; Daniel J Rader; Scott M Damrauer; Christopher J O'Donnell; Philip S Tsao
Journal:  Nat Genet       Date:  2020-06-15       Impact factor: 38.330

View more
  2 in total

Review 1.  Pathogenesis of Type 1 Diabetes: Established Facts and New Insights.

Authors:  Ana Zajec; Katarina Trebušak Podkrajšek; Tine Tesovnik; Robert Šket; Barbara Čugalj Kern; Barbara Jenko Bizjan; Darja Šmigoc Schweiger; Tadej Battelino; Jernej Kovač
Journal:  Genes (Basel)       Date:  2022-04-16       Impact factor: 4.141

Review 2.  A Final Frontier in Environment-Genome Interactions? Integrated, Multi-Omic Approaches to Predictions of Non-Communicable Disease Risk.

Authors:  Alexandra J Noble; Rachel V Purcell; Alex T Adams; Ying K Lam; Paulina M Ring; Jessica R Anderson; Amy J Osborne
Journal:  Front Genet       Date:  2022-02-08       Impact factor: 4.599

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.